A case report highlights the successful treatment of refractory pemphigus vulgaris using ultra-low-dose rituximab in a high-risk patient. This approach may offer new insights into managing this challenging autoimmune condition.
successful treatment of refractory pemphigus vulgaris with ultra low dose rituximab in a high risk patient a case report
Original title: “Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report.”